Company Research Report: Caliper Holdings

Company Overview

• Name: Caliper Holdings

• Mission: To establish cannabinoids as a new category of functional ingredients comparable to probiotics, by focusing on the necessary infrastructure to produce standardized, consistent, clinically validated consumer products.

• Founded: No information is available

• Founder(s): No information is available

• Key People: No information is available

• Headquarters: Commerce City, CO, United States

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Caliper Holdings is recognized for delivering high-quality consumer packaged goods and ingredients leveraging cannabinoids, known for their fast-acting and clinically validated effects.

Products

Ripple (THC Brand)

• Description: Ripple is the only THC brand with clinically proven fast-acting products.

• Key Features:

• Fast onset, predictable peak, and steady off-ramp of effects.

• Available primarily in state-licensed dispensaries across Colorado, New Mexico, Mississippi, Missouri, and Oklahoma.

• Products include Ripple, Ripsticks, Riplets, and Ript Gummies.

• Award-winning products in categories like Best Drink and Best-Selling Edible.

Caliper Foods (CBD Brand)

• Description: Specializes in standardized and clinically validated hemp-derived soluble cannabinoids.

• Key Features:

• Consistent delivery of consumer packaged goods incorporating cannabinoids.

• Utilizes rigorous shelf stability studies and pharmacokinetic trials.

• Contains formulations suitable for a variety of wet and dry food systems.

Recent Developments

• New Product Launches: No specific new product launches are mentioned.

• New Features Added to Existing Products: No specific new features are mentioned.

• Partnerships and Collaborations: No information is available.

Clinical Research Program

Caliper Holdings strongly emphasizes research to substantiate their product claims. Significant research studies include:

• Summer 2022: CBD PK 4 Study.

• Summer 2021: THC PK 3 Study.

• Summer 2019 – Winter 2020: CBD PK 2 Study.

• Winter 2018: THC PK I Study.

These studies focus on real-world products, involving human subjects, executed by academic clinicians and validated by publications in peer-reviewed journals.

Contact Information

• Email: ingredients@caliper.life

• Address: 6360 E 58th Ave., Unit C, Commerce City, CO 80022

Conclusion

Caliper Holdings remains a prominent player in the cannabinoid industry with its commitment to research-driven, fast-acting products under its Ripple and Caliper brands. However, more detailed information regarding financial data and corporate leadership remains unavailable based on the current data.